Correlation Between Veru and ESSA Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Veru and ESSA Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veru and ESSA Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veru Inc and ESSA Pharma, you can compare the effects of market volatilities on Veru and ESSA Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veru with a short position of ESSA Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veru and ESSA Pharma.

Diversification Opportunities for Veru and ESSA Pharma

-0.83
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Veru and ESSA is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding Veru Inc and ESSA Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ESSA Pharma and Veru is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veru Inc are associated (or correlated) with ESSA Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ESSA Pharma has no effect on the direction of Veru i.e., Veru and ESSA Pharma go up and down completely randomly.

Pair Corralation between Veru and ESSA Pharma

Given the investment horizon of 90 days Veru Inc is expected to generate 2.6 times more return on investment than ESSA Pharma. However, Veru is 2.6 times more volatile than ESSA Pharma. It trades about 0.16 of its potential returns per unit of risk. ESSA Pharma is currently generating about -0.13 per unit of risk. If you would invest  62.00  in Veru Inc on February 28, 2024 and sell it today you would earn a total of  61.00  from holding Veru Inc or generate 98.39% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy98.44%
ValuesDaily Returns

Veru Inc  vs.  ESSA Pharma

 Performance 
       Timeline  
Veru Inc 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Veru Inc are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Veru unveiled solid returns over the last few months and may actually be approaching a breakup point.
ESSA Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ESSA Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in June 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Veru and ESSA Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Veru and ESSA Pharma

The main advantage of trading using opposite Veru and ESSA Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veru position performs unexpectedly, ESSA Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ESSA Pharma will offset losses from the drop in ESSA Pharma's long position.
The idea behind Veru Inc and ESSA Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk